Alignment Healthcare, Inc. ALHC R2K
Healthcare · Healthcare Plans · United States
Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.
READ MORE ›$15.32
-0.33% 1Y
Market & Price
Market Cap
$3.17B
Current Price
$15.32
High / Low (52W)
$23.81 / $11.64
Beta
1.27
Valuation
Stock P/E
153.20
Industry PE
23.65
Forward P/E
21.20
PEG Ratio
-
Book Value
$1.00
Price to Book
15.30
P/S
0.74
EV/EBITDA
41.23
Dividend Yield
-
Profitability & Returns
ROCE
2.92%
ROE
12.53%
ROA
2.11%
Profit Margin
0.46%
Op Margin
1.29%
EPS (Latest Qtr)
$0.05
EPS (TTM)
$0.10
Balance Sheet & Liquidity
Debt/Equity
1.59
Quick Ratio
1.39
Current Ratio
1.58
Debt
$329.97M
Total Assets
$1.07B
Current Assets
$951.58M
Working Capital
$394.71M
Ownership
Promoter Holding
3.09%
Chg in Prom Hold
-0.03%
FII / Inst Holding
106.44%
Chg in FII Hold
0.00%
Financial Snapshot
Enterprise Value
$2.77B
Total Revenue (TTM)
$4.26B
EBITDA
$67.20M
Free Cash Flow
$234.58M
Operating Cash Flow
$251.99M
Shares Outstanding
206.73M
Gross Margin
12.38%
Payout Ratio
0.00%
Growth (CAGR)
Revenue 5Y
40.16%
Profit 5Y
33.17%
Revenue (YoY)
33.30%
Earnings (YoY)
-
PROS
- Compounding revenue at 40.2% over 5 years.
- Profit CAGR of 33.2% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading at a high P/E of 153.2.
- Trading 35.7% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Healthcare).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ALHC Alignment Healthcare, Inc. R2K | 15.32 | 153.20 | $3.17B | - | 2.92% | 12.53% | 40.16% | 33.17% |
| 2 | LLY Eli Lilly and Company SPX | 1,105.00 | 39.21 | $985.37B | 0.63% | 38.44% | 107.46% | 31.69% | 48.96% |
| 3 | JNJ Johnson & Johnson SPX | 225.33 | 26.11 | $542.42B | 2.38% | 23.13% | 26.42% | 5.60% | 14.32% |
| 4 | UNH UnitedHealth Group Incorporated SPX | 380.31 | 28.66 | $345.38B | 2.32% | 9.60% | 12.18% | 11.35% | -15.69% |
| 5 | MRK Merck & Co., Inc. SPX | 118.72 | 33.44 | $293.22B | 2.86% | 20.66% | 18.94% | 3.12% | 7.93% |
| 6 | TMO Thermo Fisher Scientific Inc. SPX | 492.51 | 27.11 | $183.03B | 0.38% | 9.17% | 13.52% | -0.27% | -1.19% |
| 7 | AMGN Amgen Inc. NDXSPX | 336.79 | 23.42 | $181.77B | 2.99% | 18.02% | 101.32% | 11.77% | 5.58% |
| 8 | GILD Gilead Sciences, Inc. NDXSPX | 134.43 | 18.29 | $166.90B | 2.44% | 22.92% | 43.36% | 2.57% | 22.83% |
| 9 | ISRG Intuitive Surgical, Inc. NDXSPXAI | 424.64 | 51.53 | $150.39B | - | 15.96% | 17.23% | 17.39% | 29.26% |
Ad space
Quarterly Results
Figures in USD.
| Metric | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 224.27M | 243.96M | 245.49M | 267.00M | 308.74M | 293.27M | 345.29M | 366.18M | 359.98M | 434.81M | 456.88M | 450.24M | - | - | - | - | 926.93M | 1.02B | 993.70M | 1.01B | 1.24B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 820.90M | 881.74M | 868.02M | 889.49M | 1.09B |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 106.03M | 133.55M | 125.67M | 123.31M | 144.48M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 111.42M | 110.80M | 117.99M | 133.59M | 128.98M |
| Operating Income | -5.12M | 12.59M | 15.06M | -52.66M | -40.49M | -41.45M | -36.48M | -6.65M | -33.41M | -32.49M | -23.66M | -29.76M | -41.11M | -18.38M | - | - | -5.39M | 22.75M | 7.68M | -10.28M | 15.50M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.24M | 29.86M | 15.67M | -2.45M | 23.36M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.95M | 3.95M | 3.95M | 3.95M | 4.06M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -9.33M | 18.88M | 3.73M | -14.23M | 11.44M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 21.00K | 3.22M | 2.00K | -3.23M | 25.00K |
| Net Income | -10.07M | 8.37M | 10.85M | -56.87M | -44.76M | -45.82M | -40.82M | -11.58M | -40.25M | -37.28M | -28.48M | -35.05M | -46.52M | -24.01M | - | - | -9.11M | 15.67M | 3.73M | -11.01M | 11.42M |
| Diluted EPS | - | - | - | - | -0.25 | -0.26 | -0.23 | -0.06 | -0.22 | -0.20 | -0.15 | -0.19 | -0.25 | -0.13 | - | - | -0.05 | 0.07 | 0.02 | -0.05 | 0.05 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 753.97M | 955.39M | 1.17B | 1.43B | 1.82B | 2.70B | 3.95B |
| Cost of Revenue | - | - | - | 1.25B | 1.62B | 2.41B | 3.46B |
| Gross Profit | - | - | - | 184.28M | 201.03M | 296.69M | 488.56M |
| Operating Expenses | - | - | - | 312.92M | 328.85M | 398.25M | 473.81M |
| Operating Income | -29.48M | -5.26M | -178.07M | -128.64M | -127.82M | -101.56M | 14.75M |
| EBITDA | - | - | - | -113.53M | -105.30M | -77.44M | 45.32M |
| Interest Expense | - | - | - | 18.29M | 21.23M | 23.55M | 15.80M |
| Pretax Income | - | - | - | -149.30M | -148.19M | -128.05M | -958.00K |
| Tax Provision | - | - | - | 339.00K | -22.00K | 21.00K | 20.00K |
| Net Income | -44.73M | -22.93M | -195.29M | -149.55M | -148.02M | -128.03M | -724.00K |
| Diluted EPS | - | -0.15 | -1.14 | -0.83 | -0.79 | -0.67 | 0.00 |
Compounded Sales Growth
| 5 Years: | 40.16% |
| 1 Year: | 33.30% |
Compounded Profit Growth
| 5 Years: | 33.17% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -0.33% |
| 6 Months: | -19.96% |
| 3 Months: | -20.29% |
| 1 Month: | -29.47% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 338.50M | - | 633.86M | 591.88M | 782.06M | 1.07B |
| Current Assets | - | - | - | - | 544.55M | 483.54M | 661.64M | 951.58M |
| Cash & Equivalents | - | 86.48M | 207.31M | - | 409.55M | 202.90M | 432.86M | 575.82M |
| Inventory | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | 92.89M | 119.75M | 153.90M | 253.21M |
| Total Liabilities | - | - | 307.89M | - | 394.56M | 433.81M | 681.11M | 886.51M |
| Current Liabilities | - | - | 153.45M | - | 229.96M | 263.02M | 351.85M | 556.87M |
| Long Term Debt | - | - | 144.17M | - | 160.90M | 161.81M | 321.43M | 323.18M |
| Total Debt | - | - | - | - | 164.60M | 170.79M | 329.26M | 329.64M |
| Total Equity | -33.66M | - | 30.61M | - | 238.13M | 156.95M | 99.85M | 179.28M |
| Shares Outstanding | - | - | - | - | 187.28M | 188.95M | 191.78M | 204.15M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 9.21M | 7.56M | - | -45.43M | -59.19M | 34.77M | 139.93M |
| Investing Cash Flow | -10.24M | -16.36M | - | -28.22M | -147.26M | 39.19M | -14.97M |
| Financing Cash Flow | 52.66M | 130.12M | - | 16.59M | 105.00K | 156.03M | 18.04M |
| Capital Expenditure | - | - | - | -23.77M | -35.99M | -41.42M | -26.78M |
| Free Cash Flow | - | - | - | -69.20M | -95.18M | -6.65M | 113.15M |
| Net Change in Cash | - | - | - | -57.05M | -206.34M | 229.99M | 142.99M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | 12.8% | 11.0% | 11.0% | 12.4% |
| Operating Margin % | -3.9% | -0.6% | -15.3% | -9.0% | -7.0% | -3.8% | 0.4% |
| Net Margin % | -5.9% | -2.4% | -16.7% | -10.4% | -8.1% | -4.7% | -0.0% |
| ROE % | - | -74.9% | - | -62.8% | -94.3% | -128.2% | -0.4% |
| ROCE % | - | -2.8% | - | -31.8% | -38.9% | -23.6% | 2.9% |
Shareholding Pattern
Insiders
3.09%
Institutions
106.44%
Public Float
109.83%
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Wellington Management Group, LLP | 8.27% | 17.10M | $261.96M |
| 2 | FMR, LLC | 7.69% | 15.89M | $243.47M |
| 3 | Blackrock Inc. | 6.81% | 14.08M | $215.63M |
| 4 | T. Rowe Price Investment Management, Inc. | 6.36% | 13.15M | $201.42M |
| 5 | Vanguard Portfolio Management LLC | 4.70% | 9.71M | $148.76M |
| 6 | Vanguard Capital Management LLC | 3.86% | 7.97M | $122.16M |
| 7 | Invesco Ltd. | 3.39% | 7.00M | $107.24M |
| 8 | Hood River Capital Management LLC | 2.93% | 6.05M | $92.75M |
| 9 | Price (T.Rowe) Associates Inc | 2.78% | 5.74M | $87.96M |
| 10 | Citadel Advisors Llc | 2.59% | 5.36M | $82.16M |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ALHC
No recent headlines available.